GlassScriptPhysician profile
Lori A Rogers
NPI 1205142387
$2,443.87
in general payments reported to CMS, 2019-2025
23 companies · $618 in 2025
The $618 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $189 · 2023: $694 · 2024: $695 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $602.25 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $360.95 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.79 | 2023-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $194.37 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $180.53 | 2021-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $148.00 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $136.57 | 2022-2024 | Brilinta, Farxiga, Wainua |
| Kiniksa Pharmaceuticals, LTD. | $78.09 | 2022-2023 | Arcalyst |
| Boston Scientific Corporation | $71.28 | 2023-2025 | Bodyguardian, Watchman Access System |
| Bridgebio Pharma, INC. | $45.02 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $43.95 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $34.72 | 2023-2024 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $31.86 | 2021-2024 | |
| Irhythm Technologies, INC. | $31.58 | 2023 | Zio Xt Patch |
| Atricure, INC. | $30.86 | 2023-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $30.84 | 2025 | Fibryga |
| Abbott Laboratories | $26.30 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Kestra Medical Technology Services, INC. | $25.33 | 2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $22.08 | 2025 | Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $17.50 | 2025 | |
| Esperion Therapeutics, INC. | $16.73 | 2025 | Nexletol |
| Philips North America LLC | $15.58 | 2025 | Mcot |
| Lexicon Pharmaceuticals, INC. | $13.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.